The primary goal of Project 3 is to transfer and disseminate the CMPD expertise and technology to the broader scientific community and provide access to the processing capabilities, thereby increasing the scientific impact of PSI:Biology. A particular preference will be given towards human or eukaryotic membrane proteins given the expertise and platform developed by the CMPD. Accomplishing this goal will increase the rate of successful membrane protein structure determination and more importantly to increase the impact of structural genomics efforts in answering important biomedical questions. Our collaborative experiences on membrane proteins have shown us that the most effective way to accomplish key breakthroughs are to work with researchers who are dedicated and passionate about a specific subfamily of membrane proteins (e.g. ion channels, GPCRs, monotopic enzymes, transporters). We will operate Project 3 with the ?family specific dedication? philosophy in mind. In addition to solving structures, Project 3 will also implement a vigorous community outreach program that will share expertise and HT resources used in the structure determination of membrane proteins. Thus, Project 3 will undertake two primary tasks to achieve its goal;the first is processing of network targets nominated by groups under the Consortia for High-throughput Enabled Structural Biology Partnerships and those nominated by the general community. The second is an outreach program that we envision will be beneficial not just to the groups that we will be serving, but more importantly, to the CMPD as we view outreach as opportunity for strengthening our processes and protocols through feedback provided by external groups. With Project 3, we are leveraging the breakthroughs that were enabled through technology innovation and developments in PSI-1 and JCIMPT, and have been integrated with biological knowledge in PSI-2, to expand this approach beyond the initial GPCR targets listed in Project 1.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54GM094618-04
Application #
8501567
Study Section
Special Emphasis Panel (ZGM1-CBB-3)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
4
Fiscal Year
2013
Total Cost
$445,198
Indirect Cost
$278,155
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Zhang, Haitao; Han, Gye Won; Batyuk, Alexander et al. (2017) Structural basis for selectivity and diversity in angiotensin II receptors. Nature 544:327-332
Seidel, Lisa; Zarzycka, Barbara; Zaidi, Saheem A et al. (2017) Structural insight into the activation of a class B G-protein-coupled receptor by peptide hormones in live human cells. Elife 6:
Yang, Dehua; de Graaf, Chris; Yang, Linlin et al. (2016) Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R). J Biol Chem 291:12991-3004
Zhu, Lan; Weierstall, Uwe; Cherezov, Vadim et al. (2016) Serial Femtosecond Crystallography of Membrane Proteins. Adv Exp Med Biol 922:151-160
White, Thomas A; Barty, Anton; Liu, Wei et al. (2016) Serial femtosecond crystallography datasets from G protein-coupled receptors. Sci Data 3:160057
Zhou, X Edward; Gao, Xiang; Barty, Anton et al. (2016) X-ray laser diffraction for structure determination of the rhodopsin-arrestin complex. Sci Data 3:160021
Leach, Katie; Gregory, Karen J; Kufareva, Irina et al. (2016) Towards a structural understanding of allosteric drugs at the human calcium-sensing receptor. Cell Res 26:574-92
Eddy, Matthew T; Didenko, Tatiana; Stevens, Raymond C et al. (2016) ?2-Adrenergic Receptor Conformational Response to Fusion Protein in the Third Intracellular Loop. Structure 24:2190-2197
Zheng, Yi; Qin, Ling; Zacarías, Natalia V Ortiz et al. (2016) Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists. Nature 540:458-461
Ngo, Tony; Kufareva, Irina; Coleman, James Lj et al. (2016) Identifying ligands at orphan GPCRs: current status using structure-based approaches. Br J Pharmacol 173:2934-51

Showing the most recent 10 out of 111 publications